Harbin Medical University Cancer Hospital — Heilongjiang, Harbin

Which of these are you?

🧭 Patient, caregiver or referring clinician

This page counts public registry records — it is not a list of trials you can join.

Studies recruiting near Heilongjiang →

Never medical advice — always discuss trial participation with your own doctor first.

🏢 I work at this facility, a sponsor or a CRO

Verify and correct how this facility appears in public registry records — free — and open the full registry-entry list below.

Verify this profile →

Public research footprint of Harbin Medical University Cancer Hospital, compiled from the ClinicalTrials.gov public registry.

12

Registered studies

7

Active

4

Recruiting now

4

Completed

Most-studied conditions

Locally Advanced or Metastatic Solid Tumors · Non-small Cell Lung Cancer · Advanced Esophageal Squamous Cell Carcinoma · Platinum-resistant Ovarian Cancer

Recently updated registry entries

NCT06832982 — Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacokinetics, and Preliminary… (Recruiting)
NCT04656652 — Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small… (Active Not Recruiting)
NCT07066657 — A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors (Recruiting)

7 more recent registry entries at this facility

Research staff — enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.